Annual Report 2010 (PDF, 5.2MB) - Panalpina Annual Report 2012

40
Healthcare and Chemicals
The healthcare and chemicals industry experienced a
strong recovery during 2010. A number of important trends
and regions are positively impacting the industry. The
swiftly aging population has a budget for pharmaceuticals
and is therefore pushing up the demand for life science
chemicals. India and China are two emerging economies
who are not only producing chemicals and chemical products
to meet global demand; their growing populations are
also major consumers. In the BRIC countries in general,
burgeoning middle class prosperity is boosting per-capita
spending on healthcare. US healthcare reform is also
set to ensure millions of consumers and further increase
market demand. However, the healthcare industry is under
immense cost pressure, particularly from the increase in
generic pharmaceuticals and due to new or amended health
regulations across the globe including the US and the
European Union.
Added to this is an increasing environmental awareness
among consumers coupled with increased environmental
regulations and concerns. Increasing global quality requirements
such as the Good Distribution and Manufacturing
Practice impact customers supply chain processes and lead
to rising logistics and transport costs. Panalpina considers
this to be an interesting business opportunity and offers its
customers flexible forwarding and logistics solutions and
a choice of transportation mode – air freight, ocean freight,
road or courier services – depending on urgency and consignment
size. Panalpina also offers value-added services
including an end-to-end cool chain infrastructure and forwarding
procedures which meet the industry’s hygiene,
temperature and pressure requirements through the entire
supply chain.
Panalpina Annual Report 2010